Dr. Brian M. Debroff, MD

Dr. Debroff practices at Yale Medicine in New Haven, Connecticut.

Dr. Debroff's NPI, 1346222031, was assigned on November 17, 2005. Dr. Debroff graduated from Tufts University School Of Medicine in 1989. Dr. Debroff holds Connecticut license 033564.

Dr. Debroff's primary practice is Yale Medicine, at 50 Division St, New Haven, CT 06511 in South Central Ct County. The practice phone is (203) 785-2140.

Dr. Debroff's primary practice is Yale Medicine in New Haven, Connecticut. Dr. Debroff is also affiliated with Yale New Haven Hospital. The medical group on file is Yale Health. Dmand AI also links Dr. Debroff to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Debroff practices, 3 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Debroff's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Debroff is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Debroff's licenses on file in 2 states: Connecticut and Pennsylvania.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, conjunctivitis, dry eye, eyelid inflammation, glaucoma and glaucoma surgery among the conditions Dr. Debroff treats.

CMS data shows 850 Medicare services from Dr. Debroff across 11 procedure codes in 2024, for 359 Medicare patients. Medicare paid $90,299 for them.

CMS counts 359 Medicare patients who saw Dr. Debroff in 2024. The largest group is 75 to 84, with 162 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 1.23, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Debroff's median patient age at 76, with 60% women.

In 2024, Dr. Debroff wrote 1,357 Medicare Part D claims for 303 patients. 58% of them were for generic drugs. CMS names the drug for 1,278 of them, across 21 drugs with 11 or more claims each, at $165,925 in total drug cost. In 2023, CMS named 1,493 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Debroff for performance year 2024, reported as part of a group. Dr. Debroff accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 108 procedures of cataract surgery by Dr. Debroff, more than 75% of the clinicians it reports for that procedure.

Dmand AI links 19 papers to Dr. Debroff, published from 2006 to 2025. The most frequent topics are Aqueous Humor, Cataract Extraction and Cornea. Dr. Debroff has published most often in J Cataract Refract Surg. Dr. Debroff's most frequent co-authors are Jessica Chow, MD, Vicente Antonio Diaz, MD and Mathew K. George, MD.

CMS Open Payments shows 118 general payments to Dr. Debroff from 18 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 62% of the total. Johnson & Johnson Surgical Vision, Inc. paid the most, $2,483.

Dmand AI lists 5 awards for Dr. Debroff, most recently Greenwich Magazine in 2014.

Dr. Debroff graduated from Tufts University School Of Medicine in 1989. Dr. Debroff is a member of AAO and ACS.

Dr. Debroff is in network with 17 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.